317
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis

&
Pages 1495-1502 | Received 01 Jun 2018, Accepted 14 Aug 2018, Published online: 30 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emanuele Rando, Francesca Giovannenze, Rita Murri & Emilio Sacco. (2022) A review of recent advances in the treatment of adults with complicated urinary tract infection. Expert Review of Clinical Pharmacology 15:9, pages 1053-1066.
Read now
Krisztina M. Papp-Wallace. (2019) The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections. Expert Opinion on Pharmacotherapy 20:17, pages 2169-2184.
Read now

Articles from other publishers (11)

Yan Guo, Hongtao Liu, Mengge Yang, Rui Ding, Yawen Gao, Xiaodi Niu, Xuming Deng, Jianfeng Wang, Haihua Feng & Jiazhang Qiu. (2023) Novel metallo‐β‐lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo‐lactamase‐1 (NDM‐1)‐harbouring bacteria. British Journal of Pharmacology 181:1, pages 54-69.
Crossref
Rossella Barone, Matteo Conti, Beatrice Giorgi, Milo Gatti, Pier Giorgio Cojutti, Pierluigi Viale & Federico Pea. (2023) Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem Mass Spectrometry for Therapeutic Drug Monitoring. Antibiotics 12:4, pages 719.
Crossref
Caroline Chapelle, Benjamin Gaborit, Raphaëlle Dumont, Aurélien Dinh & Maxime Vallée. (2021) Treatment of UTIs Due to Klebsiella pneumoniae Carbapenemase-Producers: How to Use New Antibiotic Drugs? A Narrative Review. Antibiotics 10:11, pages 1332.
Crossref
Sourya Bhattacharya, Aditya K. Padhi, Vivek Junghare, Neeladrisingha Das, Debashish Ghosh, Partha Roy, Kam Y.J. Zhang & Saugata Hazra. (2021) Understanding the molecular interactions of inhibitors against Bla1 beta-lactamase towards unraveling the mechanism of antimicrobial resistance. International Journal of Biological Macromolecules 177, pages 337-350.
Crossref
Nicola Ooi, Victoria E Lee, Nathan Chalam-Judge, Rebecca Newman, Andrew J Wilkinson, Ian R Cooper, David Orr, Sally Lee & Victoria J Savage. (2021) Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales. Journal of Antimicrobial Chemotherapy 76:2, pages 460-466.
Crossref
D. A. Beshnova, C. Carolan, V. G. Grigorenko, M. Yu. Rubtsova, E. Gbekor, J. Lewis, V. S. Lamzin & A. M. Egorov. (2020) Scaffold Hopping Computational Approach for Searching Novel β-Lactamase Inhibitors. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 14:2, pages 127-135.
Crossref
Davide Ceradini & Kirill Shubin. (2020) New methods for the synthesis of cyclic boronic acids (microreview). Chemistry of Heterocyclic Compounds 56:3, pages 305-307.
Crossref
Zifang Shang, Siew Yin Chan, Qing Song, Peng Li & Wei Huang. (2020) The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance. Research 2020.
Crossref
Alexey Egorov, Maya Rubtsova, Vitaly Grigorenko, Igor Uporov & Alexander Veselovsky. (2019) The Role of the Ω-Loop in Regulation of the Catalytic Activity of TEM-Type β-Lactamases. Biomolecules 9:12, pages 854.
Crossref
D.A. Beshnova, C. Carolan, V.G. Grigorenko, M.Yu. Rubtsova, E. Gbekor, J. Lewis, V.S. Lamzin & A.M. Egorov. (2019) Scaffold hopping computational approach for searching novel β-lactamase inhibitors. Biomeditsinskaya Khimiya 65:6, pages 468-476.
Crossref
Catherine L. Tooke, Philip Hinchliffe, Eilis C. Bragginton, Charlotte K. Colenso, Viivi H.A. Hirvonen, Yuiko Takebayashi & James Spencer. (2019) β-Lactamases and β-Lactamase Inhibitors in the 21st Century. Journal of Molecular Biology 431:18, pages 3472-3500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.